Shanghai Haohai plans $200m IPO in second quarter
Shanghai Haohai Biological Technology is scheduled to start investor education for its $200m IPO in Hong Kong after the Chinese New Year holidays.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: